WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RANI past revenue growth

How has RANI's revenue growth performed historically?
Company
N/A
Industry
154.55%
Market
17.87%
RANI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RANI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RANI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$34.0M
Current Profit Margin
0%

RANI Return on Equity

Current Company
-159.4%
Current Industry
-63.5%
Current Market
188%
RANI's Return on Equity (-159.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RANI announces earnings.

RANI Return on Assets

Current Company
-44.1%
Current Industry
2.9%
RANI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RANI Return on Capital Employed

Current Company
-57.85%
Current Industry
19.5%
RANI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RANI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RANI$0.00-$27.02M-$33.97M-100.00%N/A
NKTR$90.12M-$243.11M-$276.06M-40.35%N/A
INZY$0.00-$66.51M-$71.17MN/AN/A
AKBA$194.62M-$4.05M-$51.93M-1.30%N/A
XBIT$0.00-$22.57M-$24.56M-100.00%N/A
View Top Biotech Stocks

RANI earnings dates

Next earnings date
May 8, 2024

Rani Therapeutics Holdings Earnings & Revenue FAQ

What were RANI's earnings last quarter?

On Invalid Date, Rani Therapeutics Holdings (NASDAQ: RANI) reported Q4 2023 earnings per share (EPS) of -$0.27, up 22.86% year over year. Total Rani Therapeutics Holdings earnings for the quarter were -$7.10 million. In the same quarter last year, Rani Therapeutics Holdings's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.

What was RANI's earnings growth in the past year?

As of Q2 2024, Rani Therapeutics Holdings's earnings has grown year over year. Rani Therapeutics Holdings's earnings in the past year totalled -$33.97 million.

What is RANI's earnings date?

Rani Therapeutics Holdings's earnings date is Invalid Date. Add RANI to your watchlist to be reminded of RANI's next earnings announcement.

What was RANI's revenue last quarter?

On Invalid Date, Rani Therapeutics Holdings (NASDAQ: RANI) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Rani Therapeutics Holdings's revenue was $0.00.

What was RANI's revenue growth in the past year?

As of Q2 2024, Rani Therapeutics Holdings's revenue has grown null year over year. Rani Therapeutics Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.